Immunosuppression in solid organ transplantation is currently
experiencing a worldwide revival since new drugs are now available and
others are under development. In order to contribute to the design of
future strategies, a critical approach of surrogate endpoints is given
and long-term side effects are analysed, together with the impact of
non-compliance, quality-of-life and economical parameters. In this book,
international specialists have set up the scientific rationale and
provided new bases for further immunosuppressive strategies.